ImmuCell Corporation Market Risk Benefit Benefit Payment
ImmuCell Corporation (ICCC) reported Market Risk Benefit Benefit Payment of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Notes › Insurance
us-gaap:MarketRiskBenefitBenefitPayment · last filed 2022-03-30
- ImmuCell Corporation market risk benefit benefit payment for the quarter ending 2021-12-31 was $0.00.
- ImmuCell Corporation market risk benefit benefit payment for the quarter ending 2021-09-30 was $0.00.
- ImmuCell Corporation market risk benefit benefit payment for the quarter ending 2020-12-31 was $0.00.
- ImmuCell Corporation market risk benefit benefit payment for the quarter ending 2020-09-30 was $0.00.
- ImmuCell Corporation market risk benefit benefit payment for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ImmuCell Corporation market risk benefit benefit payment for fiscal 2020 was $975.00.
| Period end | Market Risk Benefit Benefit Payment 3 month | Market Risk Benefit Benefit Payment 6 month | Market Risk Benefit Benefit Payment 9 month | Market Risk Benefit Benefit Payment 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $975.00 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $975.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $975.00 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |